English

CELL GENESYS INC

EDGAR

Quarterly report (10-Q) · filed 2009-08-05

58 filing records in this dataset, filed from 1996-05-15 to 2009-08-05. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2009-06-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Cash and cash equivalents: 27.8 million USD 2009-06-30 Source
Exact value

27847000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

65.3 million USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Revenue: 17147000 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 94571000 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 47131000 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 747000 USD · 2009-01-01 – 2009-03-31 Source
Revenue: 0 USD · 2009-04-01 – 2009-06-30 Source

Net income

-34.2 million USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Net income: -8413000 USD · 2008-07-01 – 2008-09-30 Source
Net income: -46975000 USD · 2008-01-01 – 2008-12-31 Source
Net income: -33720000 USD · 2008-01-01 – 2008-09-30 Source
Net income: -8706000 USD · 2009-01-01 – 2009-03-31 Source
Net income: -3844000 USD · 2009-04-01 – 2009-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-08-05.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2008-12-31
Operating income: 10 of 11 periods available· newest 2008-12-31
Net income: 11 of 11 periods available· newest 2008-12-31
Operating cash flow: 9 of 11 periods available· newest 2006-12-31
Capital expenditure: 9 of 11 periods available· newest 2006-12-31
Total assets: 9 of 11 periods available· newest 2008-12-31
liabilities: No compatible figures in this window
Current assets: 9 of 11 periods available· newest 2008-12-31
Current liabilities: 9 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+6,753%

Prior period

USD 1.38 million

2007-01-01 – 2007-12-31
Current period

USD 94.57 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

94571000 − 1380000 = 93191000 USD

1380000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
94571000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CELL GENESYS INC · 2008-12-31 CELL GENESYS INC (edgar:865231) Year-over-year change in Revenue: 93191000 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 94571000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-09-048525.txt#3873 Input fundies:Revenue: 1380000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-09-048525.txt#3873
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 52.3 million

Prior period

−USD 99.27 million

2007-01-01 – 2007-12-31
Current period

−USD 46.98 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-46975000 − -99274000 = 52299000 USD

-99274000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-46975000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CELL GENESYS INC · 2008-12-31 CELL GENESYS INC (edgar:865231) Year-over-year change in Net income: 52299000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -46975000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-09-048525.txt#4167 Input fundies:NetIncome: -99274000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-09-048525.txt#4167
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 94.57 million 100% of revenue
Operating costs Derived USD 195.61 million 207% of revenue
Operating income −USD 101.04 million −107% of revenue
Tax, interest and other Derived −USD 54.07 million −57% of revenue
Net income −USD 46.98 million −50% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Operating loss: operating costs were 155% of revenue.
2001 Operating loss: operating costs were 285% of revenue.
2002 Operating loss: operating costs were 244% of revenue.
2003 Operating loss: operating costs were 614% of revenue.
2004 Operating loss: operating costs were 961% of revenue.
2005 Operating loss: operating costs were 2,424% of revenue.
2006 Operating loss: operating costs were 8,386% of revenue.
2007 Operating loss: operating costs were 9,169% of revenue.
2008 Operating loss: operating costs were 207% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 2000-01-01 – 2000-12-31	24209000	37458000 Derived	-13249000	-182169000 Derived	168920000	-50690000 Derived	Source 2000-01-01 – 2000-12-31: 24209000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -13249000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: 168920000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -48317000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 2373000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	28317000	80644000 Derived	-52327000	-23654000 Derived	-28673000	-59811000 Derived	Source 2001-01-01 – 2001-12-31: 28317000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -52327000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -28673000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -17623000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 42188000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	39141000	95649000 Derived	-56508000	-29909000 Derived	-26599000	-96404000 Derived	Source 2002-01-01 – 2002-12-31: 39141000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -56508000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -26599000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -30330000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 66074000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	18128000	111276000 Derived	-93148000	-36742000 Derived	-56406000	-74379000 Derived	Source 2003-01-01 – 2003-12-31: 18128000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -93148000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -56406000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -46721000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 27658000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	11458000	110061000 Derived	-98603000	-1192000 Derived	-97411000	-98243000 Derived	Source 2004-01-01 – 2004-12-31: 11458000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -98603000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -97411000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -93156000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 5087000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	4584000	111097000 Derived	-106513000	-41574000 Derived	-64939000	-108128000 Derived	Source 2005-01-01 – 2005-12-31: 4584000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -106513000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -64939000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -105939000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 2189000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	1364000	114387000 Derived	-113023000	-30094000 Derived	-82929000	-93725000 Derived	Source 2006-01-01 – 2006-12-31: 1364000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -113023000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -82929000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -91679000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 2046000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	1380000	126532000 Derived	-125152000	-25878000 Derived	-99274000	Unavailable	Source 2007-01-01 – 2007-12-31: 1380000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -125152000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -99274000 USD Inspect Net Income Open source
2008 2008-01-01 – 2008-12-31	94571000	195613000 Derived	-101042000	-54067000 Derived	-46975000	Unavailable	Source 2008-01-01 – 2008-12-31: 94571000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -101042000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -46975000 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 94.6M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Revenue	24209000	Revenue: 24209000 Open source
20012001-12-31	Revenue	28317000	Revenue: 28317000 Open source
20022002-12-31	Revenue	39141000	Revenue: 39141000 Open source
20032003-12-31	Revenue	18128000	Revenue: 18128000 Open source
20042004-12-31	Revenue	11458000	Revenue: 11458000 Open source
20052005-12-31	Revenue	4584000	Revenue: 4584000 Open source
20062006-12-31	Revenue	1364000	Revenue: 1364000 Open source
20072007-12-31	Revenue	1380000	Revenue: 1380000 Open source
20082008-12-31	Revenue	94571000	Revenue: 94571000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

6,753% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Year over year	No prior comparable period	Revenue: 24209000 Open source
20012001-12-31	Year over year	17%	Revenue: 28317000 Open source Revenue: 24209000 Open source
20022002-12-31	Year over year	38.2%	Revenue: 39141000 Open source Revenue: 28317000 Open source
20032003-12-31	Year over year	-53.7%	Revenue: 18128000 Open source Revenue: 39141000 Open source
20042004-12-31	Year over year	-36.8%	Revenue: 11458000 Open source Revenue: 18128000 Open source
20052005-12-31	Year over year	-60%	Revenue: 4584000 Open source Revenue: 11458000 Open source
20062006-12-31	Year over year	-70.2%	Revenue: 1364000 Open source Revenue: 4584000 Open source
20072007-12-31	Year over year	1.2%	Revenue: 1380000 Open source Revenue: 1364000 Open source
20082008-12-31	Year over year	6,753%	Revenue: 94571000 Open source Revenue: 1380000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -106.8% 2008

Net margin -49.7% 2008

Free cash flow margin -6,871.3% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Operating margin	-54.7%	Operating Income: -13249000 Open source Revenue: 24209000 Open source
20012001-12-31	Operating margin	-184.8%	Operating Income: -52327000 Open source Revenue: 28317000 Open source
20022002-12-31	Operating margin	-144.4%	Operating Income: -56508000 Open source Revenue: 39141000 Open source
20032003-12-31	Operating margin	-513.8%	Operating Income: -93148000 Open source Revenue: 18128000 Open source
20042004-12-31	Operating margin	-860.6%	Operating Income: -98603000 Open source Revenue: 11458000 Open source
20052005-12-31	Operating margin	-2,323.6%	Operating Income: -106513000 Open source Revenue: 4584000 Open source
20062006-12-31	Operating margin	-8,286.1%	Operating Income: -113023000 Open source Revenue: 1364000 Open source
20072007-12-31	Operating margin	-9,069%	Operating Income: -125152000 Open source Revenue: 1380000 Open source
20082008-12-31	Operating margin	-106.8%	Operating Income: -101042000 Open source Revenue: 94571000 Open source
20002000-12-31	Net margin	697.8%	Net Income: 168920000 Open source Revenue: 24209000 Open source
20012001-12-31	Net margin	-101.3%	Net Income: -28673000 Open source Revenue: 28317000 Open source
20022002-12-31	Net margin	-68%	Net Income: -26599000 Open source Revenue: 39141000 Open source
20032003-12-31	Net margin	-311.2%	Net Income: -56406000 Open source Revenue: 18128000 Open source
20042004-12-31	Net margin	-850.2%	Net Income: -97411000 Open source Revenue: 11458000 Open source
20052005-12-31	Net margin	-1,416.6%	Net Income: -64939000 Open source Revenue: 4584000 Open source
20062006-12-31	Net margin	-6,079.8%	Net Income: -82929000 Open source Revenue: 1364000 Open source
20072007-12-31	Net margin	-7,193.8%	Net Income: -99274000 Open source Revenue: 1380000 Open source
20082008-12-31	Net margin	-49.7%	Net Income: -46975000 Open source Revenue: 94571000 Open source
20002000-12-31	Free cash flow margin	-209.4%	Revenue: 24209000 Open source Operating Cash Flow: -48317000 Open source Capital Expenditure: 2373000 Open source
20012001-12-31	Free cash flow margin	-211.2%	Revenue: 28317000 Open source Operating Cash Flow: -17623000 Open source Capital Expenditure: 42188000 Open source
20022002-12-31	Free cash flow margin	-246.3%	Revenue: 39141000 Open source Operating Cash Flow: -30330000 Open source Capital Expenditure: 66074000 Open source
20032003-12-31	Free cash flow margin	-410.3%	Revenue: 18128000 Open source Operating Cash Flow: -46721000 Open source Capital Expenditure: 27658000 Open source
20042004-12-31	Free cash flow margin	-857.4%	Revenue: 11458000 Open source Operating Cash Flow: -93156000 Open source Capital Expenditure: 5087000 Open source
20052005-12-31	Free cash flow margin	-2,358.8%	Revenue: 4584000 Open source Operating Cash Flow: -105939000 Open source Capital Expenditure: 2189000 Open source
20062006-12-31	Free cash flow margin	-6,871.3%	Revenue: 1364000 Open source Operating Cash Flow: -91679000 Open source Capital Expenditure: 2046000 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 1380000 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 94571000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -91.7M 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Operating cash flow	-48317000	Operating Cash Flow: -48317000 Open source
20012001-12-31	Operating cash flow	-17623000	Operating Cash Flow: -17623000 Open source
20022002-12-31	Operating cash flow	-30330000	Operating Cash Flow: -30330000 Open source
20032003-12-31	Operating cash flow	-46721000	Operating Cash Flow: -46721000 Open source
20042004-12-31	Operating cash flow	-93156000	Operating Cash Flow: -93156000 Open source
20052005-12-31	Operating cash flow	-105939000	Operating Cash Flow: -105939000 Open source
20062006-12-31	Operating cash flow	-91679000	Operating Cash Flow: -91679000 Open source
20072007-12-31	Operating cash flow	Not reported	No source recorded
20082008-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -93.7M 2006

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Free cash flow	-50690000	Operating Cash Flow: -48317000 Open source Capital Expenditure: 2373000 Open source
20012001-12-31	Free cash flow	-59811000	Operating Cash Flow: -17623000 Open source Capital Expenditure: 42188000 Open source
20022002-12-31	Free cash flow	-96404000	Operating Cash Flow: -30330000 Open source Capital Expenditure: 66074000 Open source
20032003-12-31	Free cash flow	-74379000	Operating Cash Flow: -46721000 Open source Capital Expenditure: 27658000 Open source
20042004-12-31	Free cash flow	-98243000	Operating Cash Flow: -93156000 Open source Capital Expenditure: 5087000 Open source
20052005-12-31	Free cash flow	-108128000	Operating Cash Flow: -105939000 Open source Capital Expenditure: 2189000 Open source
20062006-12-31	Free cash flow	-93725000	Operating Cash Flow: -91679000 Open source Capital Expenditure: 2046000 Open source
20072007-12-31	Free cash flow	Unavailable	No source recorded
20082008-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2000-12-31	Liabilities / assets	Not reported	Total Assets: 793716000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 615310000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 419197000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 460502000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 435139000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 366975000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 291167000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 273392000 Open source
2008-12-31	Liabilities / assets	Not reported	Total Assets: 97973000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.59× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Current assets / current liabilities	3.3×	Current Assets: 788987000 Open source Current Liabilities: 239002000 Open source
20012001-12-31	Current assets / current liabilities	3.41×	Current Assets: 510469000 Open source Current Liabilities: 149690000 Open source
20022002-12-31	Current assets / current liabilities	3.34×	Current Assets: 196209000 Open source Current Liabilities: 58785000 Open source
20032003-12-31	Current assets / current liabilities	2.05×	Current Assets: 193397000 Open source Current Liabilities: 94296000 Open source
20042004-12-31	Current assets / current liabilities	3.1×	Current Assets: 241358000 Open source Current Liabilities: 77923000 Open source
20052005-12-31	Current assets / current liabilities	2.78×	Current Assets: 192632000 Open source Current Liabilities: 69385000 Open source
20062006-12-31	Current assets / current liabilities	3.01×	Current Assets: 154665000 Open source Current Liabilities: 51314000 Open source
20072007-12-31	Current assets / current liabilities	4.29×	Current Assets: 148348000 Open source Current Liabilities: 34565000 Open source
20082008-12-31	Current assets / current liabilities	8.59×	Current Assets: 94356000 Open source Current Liabilities: 10987000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	−USD 11.99 million Exact value Exact value: -11994000 USD 1999-01-01 – 1999-12-31: -11994000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 1999-12-31 CELL GENESYS INC (edgar:865231) Net Income: -11994000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11994000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-02-000007.txt#3372 The citation records this snapshot. The page link may show a newer release later.	−USD 2.25 million Exact value Exact value: -2249000 USD 1999-01-01 – 1999-12-31: -2249000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELL GENESYS INC · 1999-12-31 CELL GENESYS INC (edgar:865231) Operating Cash Flow: -2249000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2249000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-02-000007.txt#3390 The citation records this snapshot. The page link may show a newer release later.	USD 13,000 Exact value Exact value: 13000 USD 1999-01-01 – 1999-12-31: 13000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELL GENESYS INC · 1999-12-31 CELL GENESYS INC (edgar:865231) Capital Expenditure: 13000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-02-000007.txt#3396 The citation records this snapshot. The page link may show a newer release later.	−USD 2.26 million Calculation and evidence -2249000 − 13000 USD Exact free cash flow: -2262000 USD 1999-01-01 – 1999-12-31: -2249000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 13000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELL GENESYS INC · 1999-12-31 CELL GENESYS INC (edgar:865231) Free cash flow: -2262000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2249000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-02-000007.txt#3390 Input fundies:CapitalExpenditure: 13000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-02-000007.txt#3396 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	USD 168.92 million Exact value Exact value: 168920000 USD 2000-01-01 – 2000-12-31: 168920000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 2000-12-31 CELL GENESYS INC (edgar:865231) Net Income: 168920000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: 168920000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-03-000016.txt#3576 The citation records this snapshot. The page link may show a newer release later.	−USD 48.32 million Exact value Exact value: -48317000 USD 2000-01-01 – 2000-12-31: -48317000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELL GENESYS INC · 2000-12-31 CELL GENESYS INC (edgar:865231) Operating Cash Flow: -48317000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48317000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-03-000016.txt#3598 The citation records this snapshot. The page link may show a newer release later.	USD 2.37 million Exact value Exact value: 2373000 USD 2000-01-01 – 2000-12-31: 2373000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELL GENESYS INC · 2000-12-31 CELL GENESYS INC (edgar:865231) Capital Expenditure: 2373000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2373000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-03-000016.txt#3604 The citation records this snapshot. The page link may show a newer release later.	−USD 50.69 million Calculation and evidence -48317000 − 2373000 USD Exact free cash flow: -50690000 USD 2000-01-01 – 2000-12-31: -48317000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 2373000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELL GENESYS INC · 2000-12-31 CELL GENESYS INC (edgar:865231) Free cash flow: -50690000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48317000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-03-000016.txt#3598 Input fundies:CapitalExpenditure: 2373000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000865231-03-000016.txt#3604 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 28.67 million Exact value Exact value: -28673000 USD 2001-01-01 – 2001-12-31: -28673000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 2001-12-31 CELL GENESYS INC (edgar:865231) Net Income: -28673000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28673000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-04-034659.txt#4460 The citation records this snapshot. The page link may show a newer release later.	−USD 17.62 million Exact value Exact value: -17623000 USD 2001-01-01 – 2001-12-31: -17623000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELL GENESYS INC · 2001-12-31 CELL GENESYS INC (edgar:865231) Operating Cash Flow: -17623000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17623000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-04-034659.txt#4740 The citation records this snapshot. The page link may show a newer release later.	USD 42.19 million Exact value Exact value: 42188000 USD 2001-01-01 – 2001-12-31: 42188000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELL GENESYS INC · 2001-12-31 CELL GENESYS INC (edgar:865231) Capital Expenditure: 42188000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 42188000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-04-034659.txt#4838 The citation records this snapshot. The page link may show a newer release later.	−USD 59.81 million Calculation and evidence -17623000 − 42188000 USD Exact free cash flow: -59811000 USD 2001-01-01 – 2001-12-31: -17623000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 42188000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELL GENESYS INC · 2001-12-31 CELL GENESYS INC (edgar:865231) Free cash flow: -59811000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17623000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-04-034659.txt#4740 Input fundies:CapitalExpenditure: 42188000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-04-034659.txt#4838 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 26.6 million Exact value Exact value: -26599000 USD 2002-01-01 – 2002-12-31: -26599000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 2002-12-31 CELL GENESYS INC (edgar:865231) Net Income: -26599000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26599000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-05-004781.txt#7711 The citation records this snapshot. The page link may show a newer release later.	−USD 30.33 million Exact value Exact value: -30330000 USD 2002-01-01 – 2002-12-31: -30330000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELL GENESYS INC · 2002-12-31 CELL GENESYS INC (edgar:865231) Operating Cash Flow: -30330000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30330000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-05-004781.txt#8009 The citation records this snapshot. The page link may show a newer release later.	USD 66.07 million Exact value Exact value: 66074000 USD 2002-01-01 – 2002-12-31: 66074000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELL GENESYS INC · 2002-12-31 CELL GENESYS INC (edgar:865231) Capital Expenditure: 66074000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 66074000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-05-004781.txt#8111 The citation records this snapshot. The page link may show a newer release later.	−USD 96.4 million Calculation and evidence -30330000 − 66074000 USD Exact free cash flow: -96404000 USD 2002-01-01 – 2002-12-31: -30330000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 66074000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELL GENESYS INC · 2002-12-31 CELL GENESYS INC (edgar:865231) Free cash flow: -96404000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30330000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-05-004781.txt#8009 Input fundies:CapitalExpenditure: 66074000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-05-004781.txt#8111 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 56.41 million Exact value Exact value: -56406000 USD 2003-01-01 – 2003-12-31: -56406000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 2003-12-31 CELL GENESYS INC (edgar:865231) Net Income: -56406000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -56406000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-06-004897.txt#11825 The citation records this snapshot. The page link may show a newer release later.	−USD 46.72 million Exact value Exact value: -46721000 USD 2003-01-01 – 2003-12-31: -46721000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELL GENESYS INC · 2003-12-31 CELL GENESYS INC (edgar:865231) Operating Cash Flow: -46721000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46721000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-06-004897.txt#12194 The citation records this snapshot. The page link may show a newer release later.	USD 27.66 million Exact value Exact value: 27658000 USD 2003-01-01 – 2003-12-31: 27658000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELL GENESYS INC · 2003-12-31 CELL GENESYS INC (edgar:865231) Capital Expenditure: 27658000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27658000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-06-004897.txt#12329 The citation records this snapshot. The page link may show a newer release later.	−USD 74.38 million Calculation and evidence -46721000 − 27658000 USD Exact free cash flow: -74379000 USD 2003-01-01 – 2003-12-31: -46721000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 27658000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELL GENESYS INC · 2003-12-31 CELL GENESYS INC (edgar:865231) Free cash flow: -74379000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46721000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-06-004897.txt#12194 Input fundies:CapitalExpenditure: 27658000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-06-004897.txt#12329 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 97.41 million Exact value Exact value: -97411000 USD 2004-01-01 – 2004-12-31: -97411000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 2004-12-31 CELL GENESYS INC (edgar:865231) Net Income: -97411000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -97411000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#19523 The citation records this snapshot. The page link may show a newer release later.	−USD 93.16 million Exact value Exact value: -93156000 USD 2004-01-01 – 2004-12-31: -93156000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELL GENESYS INC · 2004-12-31 CELL GENESYS INC (edgar:865231) Operating Cash Flow: -93156000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -93156000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20272 The citation records this snapshot. The page link may show a newer release later.	USD 5.09 million Exact value Exact value: 5087000 USD 2004-01-01 – 2004-12-31: 5087000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELL GENESYS INC · 2004-12-31 CELL GENESYS INC (edgar:865231) Capital Expenditure: 5087000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5087000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20580 The citation records this snapshot. The page link may show a newer release later.	−USD 98.24 million Calculation and evidence -93156000 − 5087000 USD Exact free cash flow: -98243000 USD 2004-01-01 – 2004-12-31: -93156000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 5087000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELL GENESYS INC · 2004-12-31 CELL GENESYS INC (edgar:865231) Free cash flow: -98243000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -93156000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20272 Input fundies:CapitalExpenditure: 5087000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20580 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 64.94 million Exact value Exact value: -64939000 USD 2005-01-01 – 2005-12-31: -64939000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 2005-12-31 CELL GENESYS INC (edgar:865231) Net Income: -64939000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -64939000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-08-041870.txt#4597 The citation records this snapshot. The page link may show a newer release later.	−USD 105.94 million Exact value Exact value: -105939000 USD 2005-01-01 – 2005-12-31: -105939000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELL GENESYS INC · 2005-12-31 CELL GENESYS INC (edgar:865231) Operating Cash Flow: -105939000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -105939000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20272 The citation records this snapshot. The page link may show a newer release later.	USD 2.19 million Exact value Exact value: 2189000 USD 2005-01-01 – 2005-12-31: 2189000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELL GENESYS INC · 2005-12-31 CELL GENESYS INC (edgar:865231) Capital Expenditure: 2189000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2189000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20580 The citation records this snapshot. The page link may show a newer release later.	−USD 108.13 million Calculation and evidence -105939000 − 2189000 USD Exact free cash flow: -108128000 USD 2005-01-01 – 2005-12-31: -105939000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 2189000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELL GENESYS INC · 2005-12-31 CELL GENESYS INC (edgar:865231) Free cash flow: -108128000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -105939000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20272 Input fundies:CapitalExpenditure: 2189000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20580 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 82.93 million Exact value Exact value: -82929000 USD 2006-01-01 – 2006-12-31: -82929000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 2006-12-31 CELL GENESYS INC (edgar:865231) Net Income: -82929000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -82929000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-09-048525.txt#4167 The citation records this snapshot. The page link may show a newer release later.	−USD 91.68 million Exact value Exact value: -91679000 USD 2006-01-01 – 2006-12-31: -91679000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CELL GENESYS INC · 2006-12-31 CELL GENESYS INC (edgar:865231) Operating Cash Flow: -91679000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -91679000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20272 The citation records this snapshot. The page link may show a newer release later.	USD 2.05 million Exact value Exact value: 2046000 USD 2006-01-01 – 2006-12-31: 2046000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CELL GENESYS INC · 2006-12-31 CELL GENESYS INC (edgar:865231) Capital Expenditure: 2046000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2046000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20580 The citation records this snapshot. The page link may show a newer release later.	−USD 93.73 million Calculation and evidence -91679000 − 2046000 USD Exact free cash flow: -93725000 USD 2006-01-01 – 2006-12-31: -91679000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 2046000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CELL GENESYS INC · 2006-12-31 CELL GENESYS INC (edgar:865231) Free cash flow: -93725000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -91679000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20272 Input fundies:CapitalExpenditure: 2046000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0000950134-07-004578.txt#20580 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 99.27 million Exact value Exact value: -99274000 USD 2007-01-01 – 2007-12-31: -99274000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 2007-12-31 CELL GENESYS INC (edgar:865231) Net Income: -99274000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -99274000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-09-048525.txt#4167 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 46.98 million Exact value Exact value: -46975000 USD 2008-01-01 – 2008-12-31: -46975000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CELL GENESYS INC · 2008-12-31 CELL GENESYS INC (edgar:865231) Net Income: -46975000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T22:02:26Z Snapshot: 43f717d52a105b6e7745abe97ab6ee1a1c121fcc4d5009505c7fe316c586106d Dimensions: Consolidated View: https://fundies.io/companies/edgar/865231/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46975000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/865231/0001193125-09-048525.txt#4167 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

58 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000865231, 865231, edgar:865231

CELL GENESYS INC

Latest quarter

Revenue

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation